Milestone Pharmaceuticals (MIST)
Commercializes an etripamil nasal spray for acute adult PSVT episodes.
$1.22
Pre-market+0.04 (+3.39%)
At close$1.18(+3.51%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.20
Revenue estimate
$1.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.19−$0.31−$0.20−$0.12−$0.16−$0.20−$0.21Pending
Estimate−$0.15−$0.19−$0.18−$0.17−$0.18$0.06−$0.20−$0.20
Surprise−26.7%−63.2%−11.1%+29.4%+11.1%−433.3%−7.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported————$1.5M$238.0K$559.0KPending
Estimate————$37.5M$30.1M$816.7K$1.1M
Surprise————−96.0%−99.2%−31.6%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.20 | — | — |
| Aug 2026 | −$0.20 | −$0.21 | −7.7% |
| May 2026 | $0.06 | −$0.20 | −433.3% |
| Mar 2026 | −$0.18 | −$0.16 | +11.1% |
| Nov 2025 | −$0.17 | −$0.12 | +29.4% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| May 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.20 | — | — | $1.1M | — | — | — |
| Aug 12, 2026 | −$0.20 | −$0.21 | −7.7% | $816.7K | $559.0K | −31.6% | −11.0% |
| May 13, 2026 | $0.06 | −$0.20 | −433.3% | $30.1M | $238.0K | −99.2% | −5.2% |
| Mar 20, 2026 | −$0.18 | −$0.16 | +11.1% | $37.5M | $1.5M | −96.0% | −7.4% |
| Nov 12, 2025 | −$0.17 | −$0.12 | +29.4% | — | — | — | −1.6% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 6, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 24, 2019 | |||||||
| May 9, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||